A look at the factors driving growth and future potential in Latin America’s largest market
In recent years, the pharmaceutical sector in Latin America has experienced significant growth. This has been driven by 1) an increase in average life expectancy resulting in an expanding elderly cohort, which has additional healthcare needs, 2) an increase in disposable income, and 3) local companies’ investments in R&D. Backed by a variety of investments and the growing need for pharmaceutical innovation, Brazil has emerged as a prominent contributor to the development of specialty medications.
To learn more and read the article, please click here.
